Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $402,327 (100.0% shares, 0.0% debt)

Holdings (10)

INVA INNOVIVA INC 34.9%

Value ($000) $140,519 Shares 7,277,000 Est. Cost $13.02 Unrealized +41.6%

IRWD IRONWOOD PHARMACEUTICALS INC 16.8%

Value ($000) $67,527 Shares 16,390,000 Est. Cost $11.52 Unrealized -53.3%

GILD GILEAD SCIENCES INC 15.9%

Value ($000) $63,998 Shares 763,333 Est. Cost $58.12 Unrealized +25.7%

CYTK CYTOKINETICS INC 14.6%

Value ($000) $58,608 Shares 1,110,000 Est. Cost $64.95 Unrealized -14.2%

NBIX NEUROCRINE BIOSCIENCES INC 11.8%

Value ($000) $47,296 Shares 410,483 Est. Cost $108.95 Unrealized +25.8%

— AMARIN CORP PLC 3.9%

Value ($000) $15,579 Shares 24,850,623 Est. Cost $1.48 Unrealized —

BIIB BIOGEN INC 1.3%

Value ($000) $5,224 Shares 26,950 Est. Cost $278.12 Unrealized -24.8%

LNTH LANTHEUS HLDGS INC 0.7%

Value ($000) $2,854 Shares 26,000 Est. Cost $103.88 Unrealized 0.0%

— VOR BIOPHARMA INC 0.1%

Value ($000) $433 Shares 618,000 Est. Cost $43.10 Unrealized —

— REGULUS THERAPEUTICS INC 0.1%

Value ($000) $291 Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INVA	INNOVIVA INC	7,277,000	$140,519	34.9%	$13.02	+41.6%	COM	45781M101
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$67,527	16.8%	$11.52	-53.3%	COM CL A	46333X108
GILD	GILEAD SCIENCES INC	763,333	$63,998	15.9%	$58.12	+25.7%	COM	375558103
CYTK	CYTOKINETICS INC	1,110,000	$58,608	14.6%	$64.95	-14.2%	COM NEW	23282W605
NBIX	NEUROCRINE BIOSCIENCES INC	410,483	$47,296	11.8%	$108.95	+25.8%	COM	64125C109
—	AMARIN CORP PLC	24,850,623	$15,579	3.9%	$1.48	—	SPONS ADR NEW	023111206
BIIB	BIOGEN INC	26,950	$5,224	1.3%	$278.12	-24.8%	COM	09062X103
LNTH	LANTHEUS HLDGS INC	26,000	$2,854	0.7%	$103.88	0.0%	COM	516544103
—	VOR BIOPHARMA INC	618,000	$433	0.1%	$43.10	—	COM	929033108
—	REGULUS THERAPEUTICS INC	185,183	$291	0.1%	$2.07	—	COM	75915K309